Sign up United Kingdom
Proactive Investors - Run By Investors For Investors

Goldplat turnaround on upward momentum - CEO

Gerard Kisbey-Green, chief executive of Goldplat (LON:GDP), says the turnaround for the gold recovery specialist is on a trend which should put the company on the “up and up.”

“It’s been a good turnaround,” says Kisbey Green. “We’re not going to become complacent and there’s a lot of work to go ahead.”

Kisbey-Green tells Proactive that Goldplat is back in profit after resolving the well-documented problems with third-party South African refiner Rand. It has done this, he said, by securing alternative refiners and becoming more self-reliant after buying equipment and infrastructure.  As part of his strategy, management and operations teams were also shaken up so the right people were doing the right job.

December 2015 is Goldplat’s deadline for depleting backlog stock at the South Africa operation and Kisbey-Green predicts elution capacity will increase from 5 tonnes a day to a projected 8 tonnes.

Meet Faron Pharmaceuticals Ltd, Silence Therapeutics plc and Scancell Holdings Plc at our event, London , 01 November 2018. Register here »
View full GDP profile View Profile

Goldplat plc Timeline

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use